Cargando…
Identifying Novel Actionable Targets in Colon Cancer
Colorectal cancer is the fourth cause of death from cancer worldwide, mainly due to the high incidence of drug-resistance toward classic chemotherapeutic and newly targeted drugs. In the last decade or so, the development of novel high-throughput approaches, both genome-wide and chemical, allowed th...
Autores principales: | Cerrito, Maria Grazia, Grassilli, Emanuela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160963/ https://www.ncbi.nlm.nih.gov/pubmed/34065438 http://dx.doi.org/10.3390/biomedicines9050579 |
Ejemplares similares
-
Emerging actionable targets to treat therapy-resistant colorectal cancers
por: Grassilli, Emanuela, et al.
Publicado: (2022) -
“Ironing out” fasting-induced persister cancer cells to render chemotherapy effective: is this the solution?
por: Grassilli, Emanuela, et al.
Publicado: (2023) -
p65BTK Is a Novel Biomarker and Therapeutic Target in Solid Tumors
por: Grassilli, Emanuela, et al.
Publicado: (2021) -
Unexpected frequency of genomic alterations in histologically normal colonic tissue from colon cancer patients
por: Conconi, Donatella, et al.
Publicado: (2016) -
BTK, the new kid on the (oncology) block?
por: Grassilli, Emanuela, et al.
Publicado: (2022)